Copyright
©The Author(s) 2022.
World J Clin Cases. Dec 16, 2022; 10(35): 13058-13063
Published online Dec 16, 2022. doi: 10.12998/wjcc.v10.i35.13058
Published online Dec 16, 2022. doi: 10.12998/wjcc.v10.i35.13058
Table 2 Gene testing after the first recurrence
| Gene | Variation content | Variation ratio |
| NPM1 | Exon 11 NM_002520:c.863_864insCCAG (p.W288fs) | 11.8% (1276X) |
| TET2 | Exon 3 NM_001127208:c.1588C>T (p.Q530*) | 6.6% (2572X) |
| PTPN11 | Exon 3 NM_002834:c.218C>T (p.T73I) | 16.2% (2056X) |
| ETV6 | Exon 6 NM_001987:c.1048T>C (p.S350P) | 6.9% (1822X) |
| JAK2 | Exon 15 NM_004972:c.1975T>C (p.W659R) | 40.2% (1044X) |
| WT1 | Exon 7 NM_024426:c.1157dupC (p.A387fs) | 14.0% (1826X) |
| Exon 7 NM_024426:c.1180_1186delins8 p.R394fs) | 10.1% (1926X) |
- Citation: Wang SL. Genetic changes in refractory relapsed acute myeloid leukemia with NPM1 mutation: A case report. World J Clin Cases 2022; 10(35): 13058-13063
- URL: https://www.wjgnet.com/2307-8960/full/v10/i35/13058.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i35.13058